A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
about
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Assess Efficacy and ...... (HER) 2-Positive Breast Cancer
@en
type
label
A Study to Assess Efficacy and ...... (HER) 2-Positive Breast Cancer
@en
prefLabel
A Study to Assess Efficacy and ...... (HER) 2-Positive Breast Cancer
@en
P17
P4844
P1476
A Two-cohort, Open-label, Mult ...... ocally Advanced) Breast Cancer
@en
P1813
VELVET
@en
P3098
NCT01565083
P580
2012-04-01T00:00:00Z
P582
2015-10-01T00:00:00Z